Itau Unibanco And NeuroMetrix On The List Of Winners And Losers Of Friday’s US Premarket Session

(VIANEWS) – Good morning! Another day of trading is almost starting and here’s today’s list of stocks that have had significant trading activity in the US premarket session.

The three biggest winners today are Itau Unibanco, Fresenius Medical Care AG, and FAT Brands.

Rank Financial Asset Price Premarket
Change
Updated (EST)
1 Itau Unibanco (ITUB) 5.35 6.57% 2023-04-21 04:41:46
2 Fresenius Medical Care AG (FMS) 22.82 4.68% 2023-04-21 07:33:41
3 FAT Brands (FAT) 6.33 4.28% 2023-04-21 07:15:39
4 Xenetic Biosciences (XBIO) 0.50 3.92% 2023-04-21 07:32:21
5 Invesco (IVZ) 17.79 3.43% 2023-04-21 04:41:51
6 Aurora Cannabis (ACB) 0.63 2.7% 2023-04-21 04:47:34
7 Amazon (AMZN) 105.49 1.62% 2023-04-21 07:23:32
8 AT&T (T) 17.85 1.13% 2023-04-21 04:45:26
9 Inovio Pharmaceuticals (INO) 0.84 1.06% 2023-04-21 07:11:53
10 Southwestern Energy (SWN) 5.10 0.99% 2023-04-21 04:45:19

The three biggest losers today are NeuroMetrix, Tattooed Chef, and Banco Bilbao Vizcaya Argentaria.

Rank Financial Asset Price Premarket
Change
Updated (EST)
1 NeuroMetrix (NURO) 1.39 -2.98% 2023-04-21 04:36:00
2 Tattooed Chef (TTCF) 1.55 -1.9% 2023-04-21 04:47:51
3 Banco Bilbao Vizcaya Argentaria (BBVA) 7.33 -1.48% 2023-04-21 07:18:12
4 Credit Suisse Group (CS) 0.88 -1.15% 2023-04-21 07:32:47
5 Niu Technologies (NIU) 3.66 -1.08% 2023-04-21 07:31:11
6 Canopy Growth (CGC) 1.34 -0.7% 2023-04-21 07:23:26
7 Gap (GPS) 9.29 -0.54% 2023-04-21 04:41:08
8 Sabre Corporation (SABR) 3.77 -0.53% 2023-04-21 07:13:32
9 Nano Dimension (NNDM) 2.41 -0.41% 2023-04-21 07:31:16
10 Deutsche Bank (DB) 10.86 -0.37% 2023-04-21 07:32:55

Premarket Winners today

1. Itau Unibanco (ITUB) – Premarket: 6.57%

Itaú Unibanco Holding S.A. offers a range of financial products and services to individuals and corporate customers in Brazil and internationally. The company operates through three segments: Retail Banking, Wholesale Banking, and Activities with the Market + Corporation. It offers current account; loans; credit and debit cards; investment and commercial banking services; real estate lending services; financing and investment services; economic, financial and brokerage advisory; and leasing and foreign exchange services. The company also provides property and casualty insurance products covering loss, damage, or liabilities for assets or persons, as well as life insurance products covering death and personal accident. It serves retail customers, account and non-account holders, individuals and legal entities, high income clients, microenterprises, and small companies. The company was formerly known as Itaú Unibanco Banco Múltiplo S.A. and changed its name to Itaú Unibanco Holding S.A. in April 2009. The company was incorporated in 1924 and is headquartered in São Paulo, Brazil. Itaú Unibanco Holding S.A. is a subsidiary of IUPAR – Itaú Unibanco Participações S.A.

NYSE ended the session with Itau Unibanco jumping 0.4% to $5.02 on Friday, following the last session’s upward trend. NYSE dropped 0.45% to $15,582.94, after two successive sessions in a row of losses, on what was a somewhat negative trend exchanging session today.

Earnings Per Share

As for profitability, Itau Unibanco has a trailing twelve months EPS of $0.61.

PE Ratio

Itau Unibanco has a trailing twelve months price to earnings ratio of 8.23. Meaning, the purchaser of the share is investing $8.23 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 58.09%.

Yearly Top and Bottom Value

Itau Unibanco’s stock is valued at $5.02 at 08:34 EST, way under its 52-week high of $6.07 and way higher than its 52-week low of $3.90.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is 21.4% and 12.5%, respectively.

Dividend Yield

As maintained by Morningstar, Inc., the next dividend payment is on Jan 31, 2023, the estimated forward annual dividend rate is 0.19 and the estimated forward annual dividend yield is 3.71%.

Sales Growth

Itau Unibanco’s sales growth is 12% for the current quarter and 7.1% for the next.

More news about Itau Unibanco.

2. Fresenius Medical Care AG (FMS) – Premarket: 4.68%

Fresenius Medical Care AG & Co. KGaA provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

NYSE ended the session with Fresenius Medical Care AG falling 2.59% to $21.80 on Friday, after five sequential sessions in a row of losses. NYSE slid 0.45% to $15,582.94, after two consecutive sessions in a row of losses, on what was a somewhat bearish trend trading session today.

Earnings Per Share

As for profitability, Fresenius Medical Care AG has a trailing twelve months EPS of $1.28.

PE Ratio

Fresenius Medical Care AG has a trailing twelve months price to earnings ratio of 17.03. Meaning, the purchaser of the share is investing $17.03 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.08%.

Sales Growth

Fresenius Medical Care AG’s sales growth is 14.3% for the current quarter and 11.5% for the next.

Volatility

Fresenius Medical Care AG’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.30%, a positive 0.61%, and a positive 1.59%.

Fresenius Medical Care AG’s highest amplitude of average volatility was 1.30% (last week), 1.39% (last month), and 1.59% (last quarter).

More news about Fresenius Medical Care AG.

3. FAT Brands (FAT) – Premarket: 4.28%

FAT Brands Inc., a multi-brand restaurant company, acquires, develops, markets, and manages quick service, fast casual, casual dining, and polished casual dining restaurant concepts worldwide. It owns restaurant brands, including Round Table Pizza, Marble Slab Creamery, Great American Cookies, Hot Dog on a Stick, Pretzelmaker, Fazoli's, Fatburger, Johnny Rockets, Elevation Burger, Yalla Mediterranean, Buffalo's Cafe and Buffalo's Express, Hurricane Grill & Wings, Ponderosa Steakhouse / Bonanza Steakhouse, Native Grill & Wings, and Twin Peaks. The company was incorporated in 2017 and is headquartered in Beverly Hills, California. FAT Brands Inc. operates as a subsidiary of Fog Cutter Holdings, LLC.

NASDAQ ended the session with FAT Brands dropping 4.41% to $6.07 on Friday, after three sequential sessions in a row of losses. NASDAQ dropped 0.8% to $12,059.56, following the last session’s downward trend on what was a somewhat negative trend trading session today.

Earnings Per Share

As for profitability, FAT Brands has a trailing twelve months EPS of $-7.51.

Earnings Before Interest, Taxes, Depreciation, and Amortization

FAT Brands’s EBITDA is -47.5.

More news about FAT Brands.

4. Xenetic Biosciences (XBIO) – Premarket: 3.92%

Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology engineered to target patient-specific tumor neoantigens. The company engages in the development of biologic drugs and therapeutics. It advances cell-based therapeutics targeting the B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. In addition, the company leveraging PolyXen, its proprietary drug delivery platform, by partnering with biotechnology and pharmaceutical companies. It has collaboration agreements with Takeda Pharmaceutical Co. Ltd., Serum Institute of India Limited, and PJSC Pharmsynthez. Xenetic Biosciences, Inc. is headquartered in Framingham, Massachusetts.

NASDAQ ended the session with Xenetic Biosciences falling 7.34% to $0.48 on Friday, following the last session’s downward trend. NASDAQ dropped 0.8% to $12,059.56, following the last session’s downward trend on what was a somewhat bearish trend trading session today.

Earnings Per Share

As for profitability, Xenetic Biosciences has a trailing twelve months EPS of $-0.51.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -40.9%.

More news about Xenetic Biosciences.

5. Invesco (IVZ) – Premarket: 3.43%

Invesco Ltd. is a publicly owned investment manager. The firm provides its services to retail clients, institutional clients, high-net worth clients, public entities, corporations, unions, non-profit organizations, endowments, foundations, pension funds, financial institutions, and sovereign wealth funds. It manages separate client-focused equity and fixed income portfolios. The firm also launches equity, fixed income, commodity, multi-asset, and balanced mutual funds for its clients. It launches equity, fixed income, multi-asset, and balanced exchange-traded funds. The firm also launches and manages private funds. It invests in the public equity and fixed income markets across the globe. The firm also invests in alternative markets, such as commodities and currencies. For the equity portion of its portfolio, it invests in growth and value stocks of large-cap, mid-cap, and small-cap companies. For the fixed income portion of its portfolio, the firm invests in convertibles, government bonds, municipal bonds, treasury securities, and cash. It also invests in short term and intermediate term bonds, investment grade and high yield bonds, taxable and tax-free bonds, senior secured loans, and structured securities such as asset-backed securities, mortgage-backed securities, and commercial mortgage-backed securities. The firm employs absolute return, global macro, and long/short strategies. It employs quantitative analysis to make its investments. The firm was formerly known as Invesco Plc, AMVESCAP plc, Amvesco plc, Invesco PLC, Invesco MIM, and H. Lotery & Co. Ltd. Invesco Ltd. was founded in 1935 and is based in Atlanta, Georgia with an additional office in Hamilton, Bermuda.

NYSE ended the session with Invesco dropping 1.52% to $17.20 on Friday while NYSE dropped 0.45% to $15,582.94.

Earnings Per Share

As for profitability, Invesco has a trailing twelve months EPS of $1.49.

PE Ratio

Invesco has a trailing twelve months price to earnings ratio of 11.55. Meaning, the purchaser of the share is investing $11.55 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.52%.

More news about Invesco.

6. Aurora Cannabis (ACB) – Premarket: 2.7%

Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. The company produces, distributes, and sells medical and consumer cannabis products in Canada. It is also involved in the distribution of wholesale medical cannabis in the European Union (EU); distribution of wholesale medical cannabis in various international markets, including Australia, Caribbeans, South America, and Israel; and distribution and sale of hemp-derived cannabidiol (CBD) products in the United States (U.S.) market. In addition, the company cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, and cannabis extracts, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, edibles, and extracts; and provides dried milled strains and strain specific cannabis oils. Further, it offers patient counseling and outreach services. The company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, and WMMC. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.

NYSE ended the session with Aurora Cannabis falling 3.65% to $0.61 on Friday, after five consecutive sessions in a row of losses. NYSE fell 0.45% to $15,582.94, after two consecutive sessions in a row of losses, on what was a somewhat bearish trend trading session today.

Earnings Per Share

As for profitability, Aurora Cannabis has a trailing twelve months EPS of $-5.78.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -134.22%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 18%, now sitting on 210.49M for the twelve trailing months.

Moving Average

Aurora Cannabis’s value is way under its 50-day moving average of $0.93 and way under its 200-day moving average of $1.27.

More news about Aurora Cannabis.

7. Amazon (AMZN) – Premarket: 1.62%

Amazon.com, Inc. engages in the retail sale of consumer products and subscriptions through online and physical stores in North America and internationally. The company operates through three segments: North America, International, and Amazon Web Services (AWS). Its products offered through its stores include merchandise and content purchased for resale; and products offered by third-party sellers The company also manufactures and sells electronic devices, including Kindle, Fire tablets, Fire TVs, Rings, Blink, eero, and Echo; and develops and produces media content. In addition, it offers programs that enable sellers to sell their products in its stores; and programs that allow authors, musicians, filmmakers, Twitch streamers, skill and app developers, and others to publish and sell content. Further, the company provides compute, storage, database, analytics, machine learning, and other services, as well as fulfillment, advertising, and digital content subscriptions. Additionally, it offers Amazon Prime, a membership program. The company serves consumers, sellers, developers, enterprises, content creators, and advertisers. Amazon.com, Inc. was incorporated in 1994 and is headquartered in Seattle, Washington.

NASDAQ ended the session with Amazon dropping 0.47% to $103.81 on Friday while NASDAQ fell 0.8% to $12,059.56.

Earnings Per Share

As for profitability, Amazon has a trailing twelve months EPS of $-0.27.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -1.92%.

Moving Average

Amazon’s worth is above its 50-day moving average of $98.30 and below its 200-day moving average of $107.16.

Revenue Growth

Year-on-year quarterly revenue growth grew by 8.6%, now sitting on 513.98B for the twelve trailing months.

More news about Amazon.

8. AT&T (T) – Premarket: 1.13%

AT&T Inc. provides telecommunications and technology services worldwide. The company operates through two segments, Communications and Latin America. The Communications segment offers wireless voice and data communications services; and sells handsets, wireless data cards, wireless computing devices, and carrying cases and hands-free devices through its own company-owned stores, agents, and third-party retail stores. It also provides Virtual Private Networks, AT&T Dedicated Internet, Ethernet, data services, security, cloud solutions, outsourcing, and managed and professional services, as well as customer premises equipment for multinational corporations, small and mid-sized businesses, governmental, and wholesale customers. In addition, this segment offers broadband services, including fiber connections and legacy telephony voice communication services to residential customers. This segment markets its communications services and products under the AT&T, Cricket, AT&T PREPAID, and AT&T Fiber brand names. The Latin America segment provides postpaid and prepaid wireless services in Mexico under the AT&T and Unefon brand names, as well as sells smartphones through its owned stores, agents and third-party retail stores. The company was formerly known as SBC Communications Inc. and changed its name to AT&T Inc. in 2005. AT&T Inc. was incorporated in 1983 and is based in Dallas, Texas.

NYSE ended the session with AT&T dropping 10.41% to $17.65 on Friday while NYSE slid 0.45% to $15,582.94.

Earnings Per Share

As for profitability, AT&T has a trailing twelve months EPS of $-1.1.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -4.74%.

Volume

Today’s last reported volume for AT&T is 97853300 which is 220.11% above its average volume of 30567900.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, AT&T’s stock is considered to be overbought (>=80).

More news about AT&T.

9. Inovio Pharmaceuticals (INO) – Premarket: 1.06%

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. The company engages in conducting and planning clinical studies of its DNA medicines for HPV-associated precancers. Its products in pipeline include VGX-3100 for the treatment of HPV-related cervical high-grade dysplasia, including cervical, vulvar, and anal dysplasia and is under phase II/III clinical trials; INO-3107 for HPV-related recurrent respiratory rapillomatosis and is under Phase 1/2 trial; INO-5401 for the treatment of glioblastoma multiforme and is under Phase 2 trial; INO-4201 for Ebola Virus Disease and is under phase 1b trial; and INO-4500 vaccine for lassa fever, which is under phase 1b trial. Its partners and collaborators include Advaccine Biopharmaceuticals Suzhou Co, ApolloBio Corporation, AstraZeneca, The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations, Defense Advanced Research Projects Agency, The U.S. Department of Defense, HIV Vaccines Trial Network, International Vaccine Institute, Kaneka Eurogentec, National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, the Parker Institute for Cancer Immunotherapy, Plumbline Life Sciences, Regeneron Pharmaceuticals, Richter-Helm BioLogics, Thermo Fisher Scientific, the University of Pennsylvania, the Walter Reed Army Institute of Research, and The Wistar Institute. The company was incorporated in 1983 and is headquartered in Plymouth Meeting, Pennsylvania.

NASDAQ ended the session with Inovio Pharmaceuticals sliding 6.02% to $0.83 on Friday while NASDAQ fell 0.8% to $12,059.56.

Earnings Per Share

As for profitability, Inovio Pharmaceuticals has a trailing twelve months EPS of $-1.17.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -89.97%.

Sales Growth

Inovio Pharmaceuticals’s sales growth is 35.7% for the ongoing quarter and negative 65.6% for the next.

Moving Average

Inovio Pharmaceuticals’s worth is way below its 50-day moving average of $1.19 and way below its 200-day moving average of $1.77.

Revenue Growth

Year-on-year quarterly revenue growth declined by 85.1%, now sitting on 10.26M for the twelve trailing months.

More news about Inovio Pharmaceuticals.

10. Southwestern Energy (SWN) – Premarket: 0.99%

Southwestern Energy Company, an independent energy company, engages in the exploration, development, and production of natural gas, oil, and natural gas liquids (NGLs) in the United States. It operates through two segments, Exploration and Production, and Marketing. The company focuses on the development of unconventional natural gas and oil reservoirs located in Pennsylvania, West Virginia, Ohio, and Louisiana. It also engages in the marketing and transportation of natural gas, oil, and NGLs. The company serves LNG exporters, energy companies, utilities, and industrial purchasers of natural gas. Southwestern Energy Company was incorporated in 1929 and is headquartered in Spring, Texas.

NYSE ended the session with Southwestern Energy jumping 0.5% to $5.05 on Friday while NYSE dropped 0.45% to $15,582.94.

Earnings Per Share

As for profitability, Southwestern Energy has a trailing twelve months EPS of $1.63.

PE Ratio

Southwestern Energy has a trailing twelve months price to earnings ratio of 3.1. Meaning, the purchaser of the share is investing $3.1 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 53.82%.

Volatility

Southwestern Energy’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.86%, a positive 0.29%, and a positive 2.64%.

Southwestern Energy’s highest amplitude of average volatility was 1.12% (last week), 1.76% (last month), and 2.64% (last quarter).

Volume

Today’s last reported volume for Southwestern Energy is 11482100 which is 55.89% below its average volume of 26036200.

More news about Southwestern Energy.

Premarket Losers Today

1. NeuroMetrix (NURO) – Premarket: -2.98%

NeuroMetrix, Inc., a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. Its primary marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system, a platform for the performance of nerve conduction studies. The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physicians; occupational health, primary care, internal medicine, orthopedic, and hand surgeons; and pain medicine physicians, neurologists, physical medicine and rehabilitation physicians, and neurosurgeons. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.

NASDAQ ended the session with NeuroMetrix falling 2.05% to $1.43 on Friday, following the last session’s downward trend. NASDAQ slid 0.8% to $12,059.56, following the last session’s downward trend on what was a somewhat bearish trend trading session today.

Earnings Per Share

As for profitability, NeuroMetrix has a trailing twelve months EPS of $-0.63.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -18.97%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, NeuroMetrix’s stock is considered to be overbought (>=80).

Earnings Before Interest, Taxes, Depreciation, and Amortization

NeuroMetrix’s EBITDA is 10.38.

More news about NeuroMetrix.

2. Tattooed Chef (TTCF) – Premarket: -1.9%

Tattooed Chef, Inc., a plant-based food company, produces and sells a portfolio of frozen foods. It supplies plant-based products to retailers in the United States. The company offers ready-to-cook bowls, zucchini spirals, riced cauliflower, acai and smoothie bowls, cauliflower crust pizza, and plant-based burgers. Its products are available in private label and Tattooed Chef brand name in the frozen food section of retail food stores. As of December 31, 2021, it operated approximately 14,000 retail outlets. Tattooed Chef, Inc. is headquartered in Paramount, California.

NASDAQ ended the session with Tattooed Chef dropping 5.39% to $1.58 on Friday while NASDAQ slid 0.8% to $12,059.56.

Earnings Per Share

As for profitability, Tattooed Chef has a trailing twelve months EPS of $-1.29.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -53.72%.

More news about Tattooed Chef.

3. Banco Bilbao Vizcaya Argentaria (BBVA) – Premarket: -1.48%

Banco Bilbao Vizcaya Argentaria, S.A., together with its subsidiaries, provides retail banking, wholesale banking, and asset management services. It offers current accounts; and demand, savings, overnight, time, term, and subordinated deposits. The company also provides loan products; deals in securities; leasing, factoring, brokerage, and asset management services; and manages pension and investment funds. In addition, it offers credit cards; corporate and investment banking services; insurance products and services; and real estate services. The company provides its products through online and mobile channels. It operates in Spain, Mexico, South America, the United States, Turkey, Asia, and rest of Europe. Banco Bilbao Vizcaya Argentaria, S.A. was founded in 1857 and is headquartered in Bilbao, Spain.

NYSE ended the session with Banco Bilbao Vizcaya Argentaria falling 1.72% to $7.44 on Friday while NYSE slid 0.45% to $15,582.94.

Earnings Per Share

As for profitability, Banco Bilbao Vizcaya Argentaria has a trailing twelve months EPS of $1.08.

PE Ratio

Banco Bilbao Vizcaya Argentaria has a trailing twelve months price to earnings ratio of 6.89. Meaning, the purchaser of the share is investing $6.89 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.25%.

Moving Average

Banco Bilbao Vizcaya Argentaria’s value is higher than its 50-day moving average of $7.19 and way higher than its 200-day moving average of $5.55.

Revenue Growth

Year-on-year quarterly revenue growth grew by 15%, now sitting on 21.51B for the twelve trailing months.

Dividend Yield

According to Morningstar, Inc., the next dividend payment is on Oct 6, 2022, the estimated forward annual dividend rate is 0.46 and the estimated forward annual dividend yield is 6.29%.

More news about Banco Bilbao Vizcaya Argentaria.

4. Credit Suisse Group (CS) – Premarket: -1.15%

Credit Suisse Group AG, together with its subsidiaries, provides various financial services in Switzerland, Europe, the Middle East, Africa, the Americas, and Asia Pacific. The company offers wealth management solutions, including investment advice and discretionary asset management services; risk management solutions, such as managed investment products; and wealth and succession planning. It also provides financing and lending solutions, including consumer credit and real estate mortgage lending, real asset lending relating to ship, and aviation financing for UHNWI; standard and structured hedging, and lombard lending solutions, as well as collateral trading services; and investment banking solutions, such as global securities sales, trading and execution, capital raising, and advisory services. In addition, the company offers banking solutions, such as payments, accounts, debit and credit cards, product bundles, and mortgages; asset management products; equity and debt capital markets, and advisory services; cash equities, equity derivatives, and convertibles, as well as prime services and fixed income products, such as credit, securitized, macro, emerging markets, financing, structured credit, and other products. Further, it provides HOLT, a framework for assessing the performance of approximately 20,000 companies; and equity and fixed income research services. The company serves private and institutional clients; ultra-high-net-worth individuals, high-net-worth individuals, and affluent and retail clients; corporate clients, small and medium-sized enterprises, external asset managers, financial institutions, and commodity traders; and pension funds, hedge funds, governments, foundations and endowments, corporations, entrepreneurs, private individuals, and financial sponsors. Credit Suisse Group AG was founded in 1856 and is based in Zurich, Switzerland.

NYSE ended the session with Credit Suisse Group falling 2.73% to $0.89 on Friday, after two sequential sessions in a row of losses. NYSE fell 0.45% to $15,582.94, after two successive sessions in a row of losses, on what was a somewhat down trend exchanging session today.

Earnings Per Share

As for profitability, Credit Suisse Group has a trailing twelve months EPS of $-2.84.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -18.09%.

Yearly Top and Bottom Value

Credit Suisse Group’s stock is valued at $0.89 at 08:34 EST, way below its 52-week high of $8.29 and above its 52-week low of $0.82.

Volume

Today’s last reported volume for Credit Suisse Group is 7577740 which is 84.21% below its average volume of 48014000.

More news about Credit Suisse Group.

5. Niu Technologies (NIU) – Premarket: -1.08%

Niu Technologies designs, manufactures, and sells smart electric scooters in the People's Republic of China. The company offers NQi, MQi, UQi, and Gova series electric scooters and motorcycles; KQi series electric kick-scooters; NIU Aero and BQi series e-bikes; RQi and TQi series high-performance motorcycles; and YQi series hybrid motorcycles. It also provides accessories and spare parts under the NIU brand name comprising scooter accessories, such as raincoats, gloves, knee pads, storage baskets and tail boxes, smart phone holders, backrests, and locks; lifestyle accessories, which includes T-shirts, coats, sweaters and hoodies, jeans, hats, bags, jewelry, notebook, badges, key chain, and mugs; and performance upgrade components that comprises of upgraded wheels, shock absorbers, brake calipers, and carbon fiber body panels. In addition, the company, through its NIU app, offers online repair request, DIY repairs, service station locator, theft reporting, and smart services, as well as NIU cover, which provides insurance services; NIU Care that offers maintenance and reserve services in offline service stations; and NIU Wash, which provides free wash coupon on a monthly basis. Niu Technologies sells and services its products through city partners and franchised stores, distributors, and third-party e-commerce platforms and the company's online store. As of December 31, 2021, it operated through 338 city partners and 3,108 franchised stores in approximately 239 cities in the People's Republic of China; and 42 distributors in 50 countries internationally. Niu Technologies was incorporated in 2014 and is headquartered in Beijing, the People's Republic of China.

NASDAQ ended the session with Niu Technologies rising 0.14% to $3.70 on Friday, following the last session’s upward trend. NASDAQ fell 0.8% to $12,059.56, following the last session’s downward trend on what was a somewhat bearish trend trading session today.

Earnings Per Share

As for profitability, Niu Technologies has a trailing twelve months EPS of $-0.09.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -3.84%.

Sales Growth

Niu Technologies’s sales growth for the current quarter is 28.5%.

Volume

Today’s last reported volume for Niu Technologies is 339925 which is 41% below its average volume of 576193.

Yearly Top and Bottom Value

Niu Technologies’s stock is valued at $3.70 at 08:34 EST, way under its 52-week high of $9.99 and way higher than its 52-week low of $2.57.

More news about Niu Technologies.

6. Canopy Growth (CGC) – Premarket: -0.7%

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.

NASDAQ ended the session with Canopy Growth dropping 5.59% to $1.35 on Friday, after five consecutive sessions in a row of losses. NASDAQ dropped 0.8% to $12,059.56, following the last session’s downward trend on what was a somewhat negative trend exchanging session today.

Earnings Per Share

As for profitability, Canopy Growth has a trailing twelve months EPS of $-5.3.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -112%.

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is 86.8% and 96.6%, respectively.

Yearly Top and Bottom Value

Canopy Growth’s stock is valued at $1.35 at 08:34 EST, below its 52-week low of $1.43.

More news about Canopy Growth.

7. Gap (GPS) – Premarket: -0.54%

The Gap, Inc. operates as an apparel retail company. The company offers apparel, accessories, and personal care products for men, women, and children under the Old Navy, Gap, Banana Republic, and Athleta brands. Its products include denim and khakis; eyewear, jewelry, shoes, handbags, and fragrances; and fitness and lifestyle products for use in yoga, training, sports, travel, and everyday activities for women and girls. The company offers its products through company-operated stores, franchise stores, websites, and third-party arrangements. It has franchise agreements to operate Old Navy, Gap, Banana Republic, and Athleta stores and websites in Asia, Europe, Latin America, the Middle East, and Africa. The company also provides its products through e-commerce sites. The Gap, Inc. was incorporated in 1969 and is headquartered in San Francisco, California.

NYSE ended the session with Gap sliding 3.36% to $9.34 on Friday, following the last session’s downward trend. NYSE slid 0.45% to $15,582.94, after two consecutive sessions in a row of losses, on what was a somewhat bearish trend exchanging session today.

Earnings Per Share

As for profitability, Gap has a trailing twelve months EPS of $-0.55.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -8.15%.

Moving Average

Gap’s value is way under its 50-day moving average of $11.49 and way below its 200-day moving average of $11.07.

Dividend Yield

According to Morningstar, Inc., the next dividend payment is on Apr 3, 2023, the estimated forward annual dividend rate is 0.6 and the estimated forward annual dividend yield is 6.42%.

Volume

Today’s last reported volume for Gap is 3301690 which is 61.74% below its average volume of 8631840.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Gap’s EBITDA is 0.55.

Previous days news about Gap

  • Gap (gps) partners with mattel to enhance collection. According to Zacks on Thursday, 20 April, "We note that the first of several upcoming Gap x Mattel product drops are likely to be the Gap x Barbie collection. ", "Other Gap x Mattel collaborations will be revealed later this year, which will include apparel based on the world’s top-selling toy, Hot Wheels. "

More news about Gap.

8. Sabre Corporation (SABR) – Premarket: -0.53%

Sabre Corporation, through its subsidiaries, provides software and technology solutions for the travel industry worldwide. It operates in two segments, Travel Solutions and Hospitality Solutions. The Travel Solutions segment operates a business-to-business travel marketplace that offers travel content, such as inventory, prices, and availability from a range of travel suppliers, including airlines, hotels, car rental brands, rail carriers, cruise lines, and tour operators with a network of travel buyers comprising online and offline travel agencies, travel management companies, and corporate travel departments. This segment also provides a portfolio of software technology products and solutions through software-as-a-service (SaaS) and hosted delivery models to airlines and other travel suppliers. Its products include reservation systems for carriers, commercial and operations products, agency solutions, and data-driven intelligence solutions. The Hospitality Solutions segment provides software and solutions to hoteliers through SaaS and hosted delivery models. Sabre Corporation was incorporated in 2006 and is headquartered in Southlake, Texas.

NASDAQ ended the session with Sabre Corporation falling 2.57% to $3.79 on Friday while NASDAQ slid 0.8% to $12,059.56.

Earnings Per Share

As for profitability, Sabre Corporation has a trailing twelve months EPS of $-1.38.

More news about Sabre Corporation.

9. Nano Dimension (NNDM) – Premarket: -0.41%

Nano Dimension Ltd., together with its subsidiaries, provides additive electronics in Israel and internationally. The company offers 3D printers, comprising DragonFly IV that produces Hi-PEDs by depositing proprietary conductive and dielectric substances, as well as integrates in-situ capacitors, antennas, coils, transformers, and electromechanical components; digital light processing printers (DLP) that achieves production-grade polymer and composite parts; and admaflex that utilizes a patented DLP foil system that fabricates ceramic and metal parts. It also provides additive electronics robotics and control systems, which includes surface-mount-technology, an electronics assembly equipment for electronic components on Hi-PEDs and PCBs, catering to various manufacturing and volume requirements; and ink delivery systems controls electronics, software, and ink delivery systems for digital printing. In addition, the company offers software to provide engineers with the tools to bring precision and electrical parts from design-to-manufacturing, as well as sells various materials that are developed in-house. Nano Dimension Ltd. was incorporated in 1960 and is headquartered in Ness Ziona, Israel.

NASDAQ ended the session with Nano Dimension sliding 2.16% to $2.42 on Friday while NASDAQ dropped 0.8% to $12,059.56.

Earnings Per Share

As for profitability, Nano Dimension has a trailing twelve months EPS of $-0.88.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -22.01%.

Volatility

Nano Dimension’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.27%, a positive 0.42%, and a positive 2.88%.

Nano Dimension’s highest amplitude of average volatility was 1.34% (last week), 2.94% (last month), and 2.88% (last quarter).

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Nano Dimension’s stock is considered to be overbought (>=80).

More news about Nano Dimension.

10. Deutsche Bank (DB) – Premarket: -0.37%

Deutsche Bank Aktiengesellschaft, operates as a stock corporation, engages in the provision of corporate and investment banking, and asset management products and services to private clients, corporate entities, and institutional clients worldwide. Its Corporate Bank segment provides cash management, trade finance and lending, trust and agency, foreign exchange, and securities services, as well as risk management solutions. The company's Investment Bank segment offers debt origination, merger and acquisitions, and equity advisory services. Its Private Bank segment provides payment and account services, and credit and deposit products, as well as investment advice products, such as environmental, social, and governance products. This segment also provides banking, wealth management services, postal and parcel services; and offers support in planning, managing and investing wealth, financing personal and business interests, and servicing institutional and corporate needs. The company's Asset Management segment provides investment solutions, such as alternative investments, which include real estate, infrastructure, private equity, liquid real assets, and sustainable investments; and various other services, including insurance and pension solutions, asset liability management, portfolio management solutions, and asset allocation advisory to individuals and institutions. Deutsche Bank Aktiengesellschaft was founded in 1870 and is based in Frankfurt am Main, Germany.

NYSE ended the session with Deutsche Bank dropping 1.22% to $10.90 on Friday, following the last session’s downward trend. NYSE fell 0.45% to $15,582.94, after two sequential sessions in a row of losses, on what was a somewhat bearish trend exchanging session today.

Earnings Per Share

As for profitability, Deutsche Bank has a trailing twelve months EPS of $2.57.

PE Ratio

Deutsche Bank has a trailing twelve months price to earnings ratio of 4.24. Meaning, the purchaser of the share is investing $4.24 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.86%.

Volume

Today’s last reported volume for Deutsche Bank is 1883910 which is 62.69% below its average volume of 5049480.

Revenue Growth

Year-on-year quarterly revenue growth declined by 1.1%, now sitting on 25.68B for the twelve trailing months.

Yearly Top and Bottom Value

Deutsche Bank’s stock is valued at $10.90 at 08:34 EST, way under its 52-week high of $13.57 and way above its 52-week low of $7.25.

More news about Deutsche Bank.

Stay up to date with our premarket winners and losers daily report

Leave a Reply

Your email address will not be published. Required fields are marked *